Immunic, Inc. Current Liabilities
Immunic, Inc. (IMUX) had Current Liabilities of $31.26 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-11
- 2026-06-30: Liabilities, Current $31.26M.
- 2026-03-31: Liabilities, Current $38.36M.
- 2025-12-31: Liabilities, Current $30.62M.
- 2025-09-30: Liabilities, Current $30.08M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $31.26M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $38.36M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $30.62M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $30.08M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $27.31M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $25.59M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $22.18M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $23.36M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $22.68M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $20.15M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $24.73M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $17.78M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $18.24M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $16.30M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $13.08M 10-K · filed 2024-02-22 | |
| 2022-09-30 | $11.51M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $10.40M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $11.46M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $11.40M 10-K · filed 2023-02-23 | |
| 2021-09-30 | $10.59M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $14.49M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $16.36M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $8.40M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $8.03M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $7.67M 10-Q · filed 2020-08-03 | |
| 2020-03-31 | $6.33M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $7.07M 10-K · filed 2021-02-26 | |
| 2019-09-30 | $7.04M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $3.12M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $1.43M 10-Q · filed 2019-04-10 | |
| 2018-12-31 | $1.92M 10-K · filed 2020-03-16 | $2.51M 10-K · filed 2019-03-04 |
| 2018-09-30 | $5.69M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $8.30M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $9.67M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $10.28M 10-K · filed 2019-03-04 | |
| 2017-09-30 | $8.23M 10-Q · filed 2017-10-25 | |
| 2017-06-30 | $7.29M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $6.45M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $5.48M 10-K · filed 2018-03-13 | |
| 2016-09-30 | $4.63M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $4.47M 10-Q · filed 2016-08-02 | |
| 2016-03-31 | $4.82M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $6.66M 10-K · filed 2017-03-07 | |
| 2015-09-30 | $8.12M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $9.98M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $10.95M 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $10.28M 10-K · filed 2016-03-08 | |
| 2014-09-30 | $8.50M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $7.56M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $8.63M 10-Q · filed 2014-05-28 | |
| 2013-12-31 | $7.45M 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B |